Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

Explore how neutrophils shape the immune response in health and disease. This poster highlights neutrophil pathogen defense mechanisms, including phagocytosis, degranulation, and NETosis, as well as neutrophil roles in inflammation and NET-associated pathologies.
DOWNLOAD NOWSimnotrelvir is an inhibitor of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) main protease (Mpro), also known as 3C-like protease (3Cpro; IC50 = 9 nM).1 It is selective for Mpro over chymotrypsin at 20 µM, cathepsin A, D, E, and L at 100 µM, and a panel of 413 kinases at 10 µM. Simnotrelvir (200 mg/kg, p.o.) reduces lung and brain viral titers, alveolar atrophy, alveolar septal thickening, and neuron degeneration when administered with ritonavir (Item No. 13872) in a mouse model of SARS-CoV-2 infection.
WARNING This product is not for human or veterinary use.
1. Structure-